Livingston B D, Jacobs J L, Glick M C, Troy F A
Department of Biological Chemistry, University of California School of Medicine, Davis 95616.
J Biol Chem. 1988 Jul 5;263(19):9443-8.
Polysialic acid-containing glycoproteins consisting of extended chains of at least 55 sialyl residues (DP55, where DP represents degree of polymerization) are expressed on human neuroblastoma cells, CHP-134. The strategy used for detecting these unique carbohydrate structures was based on the use of two highly specific prokaryotic-derived enzyme systems and an anti-polysialosyl antibody (H.46). These probes were developed for the detection of polysialic acid on neural cell adhesion molecules (Troy, F. A., Hallenbeck, P. C., McCoy, R. D., and Vimr, E. R. (1987) Methods Enzymol. 138, 169-185). Proof for the presence of long chain multimers of sialic acid was based on two types of experiments which utilized: 1) a glycopeptide fraction of CHP-134 cells, labeled metabolically with D-[3H]GlcN and 2) a membrane fraction from CHP-134 cells which served as an exogenous acceptor of [14C] NeuNAc residues in an Escherichia coli K1 sialyltransferase assay. In vitro, this enzyme CMP-NeuNAc:poly-alpha-2,8-sialosyl sialyltransferase catalyzes the transfer of [14C]NeuNAc from CMP-[14C]NeuNAc to exogenous acceptors containing at least 3 sialyl residues. In the first series of experiments, endo-N-acetylneuraminidase (Endo-N), a bacteriophage-derived enzyme specific for hydrolyzing poly-alpha-2,8-sialosyl chains containing a minimum of 5 sialyl residues was used. Limit Endo-N digestion of the 3H-glycopeptides from the [3H] GlcN-labeled cells released short [3H]sialyl oligomers [( 3H]DP1-6) which were degraded to [3H]NeuNAc by exosialidase. Partial Endo-N digestion released a series of [3H]sialyl oligomers extending up to DP55. The longer (DP20-55) and intermediate sized (DP10-20) oligomers were isolated and converted to short oligomers ((3H]DP1-6) by retreating with Endo-N, thus confirming their identity as homo-oligomers of alpha-2,8-linked [3H]NeuNAc residues. In the second series of experiments, a membrane fraction of CHP-134 cells was radiolabeled in vitro with [14C]NeuNAc by E. coli K1 sialyltransferase. The membrane fraction had a major portion of radioactivity that was high Mr and polydisperse (Mr 100,000-250,000) as demonstrated in sodium dodecyl sulfate-polyacrylamide gels. Using Western blotting, pre-existing material of similar size was shown to react with antibody H.46.(ABSTRACT TRUNCATED AT 400 WORDS)
由至少55个唾液酸残基的延伸链组成的含多唾液酸糖蛋白(聚合度DP55,其中DP代表聚合度)在人神经母细胞瘤细胞CHP-134上表达。用于检测这些独特碳水化合物结构的策略基于使用两种高度特异性的原核生物衍生酶系统和一种抗多唾液酸基抗体(H.46)。这些探针是为检测神经细胞粘附分子上的多唾液酸而开发的(特洛伊,F.A.,哈伦贝克,P.C.,麦科伊,R.D.,和维姆尔,E.R.(1987年)《酶学方法》138卷,169 - 185页)。唾液酸长链多聚体存在的证据基于两类实验,这些实验利用了:1)CHP-134细胞的糖肽部分,用D-[3H]葡糖胺进行代谢标记;2)CHP-134细胞的膜部分,在大肠杆菌K1唾液酸转移酶测定中用作[14C]N-乙酰神经氨酸残基的外源受体。在体外,这种酶CMP-N-乙酰神经氨酸:聚-α-2,8-唾液酸基唾液酸转移酶催化[14C]N-乙酰神经氨酸从CMP-[14C]N-乙酰神经氨酸转移到含有至少3个唾液酸残基的外源受体上。在第一系列实验中,使用了内切N-乙酰神经氨酸酶(内切N),一种噬菌体衍生的酶,专门用于水解含有至少5个唾液酸残基的聚-α-2,8-唾液酸链。对来自[3H]葡糖胺标记细胞的3H-糖肽进行内切N的极限消化,释放出短的[3H]唾液酸寡聚体([3H]DP1 - 6),这些寡聚体被外切唾液酸酶降解为[3H]N-乙酰神经氨酸。内切N的部分消化释放出一系列延伸至DP55的[3H]唾液酸寡聚体。较长的(DP20 - 55)和中等大小的(DP10 - 20)寡聚体被分离出来,并通过用内切N再次处理转化为短寡聚体([3H]DP1 - 6),从而证实它们是α-2,8-连接的[3H]N-乙酰神经氨酸残基的同聚体。在第二系列实验中,CHP-134细胞的膜部分在体外通过大肠杆菌K1唾液酸转移酶用[14C]N-乙酰神经氨酸进行放射性标记。如在十二烷基硫酸钠-聚丙烯酰胺凝胶中所示,膜部分的大部分放射性物质是高分子量且多分散的(分子量100,000 - 250,000)。使用蛋白质印迹法,显示出预先存在的类似大小的物质与抗体H.46发生反应。(摘要截断于400字)